Palisade Bio Past Earnings Performance
Past criteria checks 0/6
Palisade Bio has been growing earnings at an average annual rate of 6%, while the Pharmaceuticals industry saw earnings growing at 8.4% annually. Revenues have been growing at an average rate of 99.9% per year.
Key information
6.0%
Earnings growth rate
25.7%
EPS growth rate
| Pharmaceuticals Industry Growth | 7.3% |
| Revenue growth rate | 99.9% |
| Return on equity | -134.0% |
| Net Margin | n/a |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Palisade Bio makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 0 | -14 | 6 | 8 |
| 31 Dec 23 | 0 | -12 | 6 | 7 |
| 30 Sep 23 | 0 | -13 | 6 | 8 |
| 30 Jun 23 | 0 | -14 | 7 | 8 |
| 31 Mar 23 | 0 | -13 | 7 | 7 |
| 31 Dec 22 | 0 | -15 | 9 | 7 |
| 30 Sep 22 | 0 | -9 | 10 | 5 |
| 30 Jun 22 | 0 | 0 | 11 | 4 |
| 31 Mar 22 | 0 | -27 | 11 | 3 |
| 31 Dec 21 | 0 | -27 | 9 | 2 |
| 30 Sep 21 | 0 | -32 | 9 | 2 |
| 30 Jun 21 | 0 | -39 | 8 | 2 |
| 31 Mar 21 | 0 | -12 | 6 | 3 |
| 31 Dec 20 | 0 | -10 | 6 | 3 |
| 30 Sep 20 | 0 | -9 | 6 | 3 |
| 31 Dec 19 | 0 | -10 | 7 | 3 |
| 31 Dec 18 | 1 | -4 | 4 | 1 |
Quality Earnings: 7NS0 is currently unprofitable.
Growing Profit Margin: 7NS0 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 7NS0 is unprofitable, but has reduced losses over the past 5 years at a rate of 6% per year.
Accelerating Growth: Unable to compare 7NS0's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 7NS0 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (1.5%).
Return on Equity
High ROE: 7NS0 has a negative Return on Equity (-134.01%), as it is currently unprofitable.